Clinical relevance of advances in genetics and pharmacogenetics of IBD
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 126 (6) , 1533-1549
- https://doi.org/10.1053/j.gastro.2004.01.061
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- MDR1 Ala893 Polymorphism Is Associated with Inflammatory Bowel DiseaseAmerican Journal of Human Genetics, 2003
- Mistaken identityEuropean Journal of Gastroenterology & Hepatology, 2003
- IBD5 is a General Risk Factor for Inflammatory Bowel Disease: Replication of Association with Crohn Disease and Identification of a Novel Association with Ulcerative ColitisAmerican Journal of Human Genetics, 2003
- Do inflammatory bowel disease (IBD) patients want genetic testing?Gastroenterology, 2003
- Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's diseaseGut, 2003
- Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB ActivationJournal of Biological Chemistry, 2002
- Candidate-gene approaches for studying complex genetic traits: practical considerationsNature Reviews Genetics, 2002
- Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κBJournal of Biological Chemistry, 2001
- Getting the right drug into the right patientNature Biotechnology, 1997
- Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 1995